Furthermore, the activation of the AMPK pathway has also demonstrated the ability to restrain dysfunctional vascular growth, a significant contributor to cardiovascular disease, by inhibiting TGF-β [45]. This evidence concerns the gene TGFB1 and cardiovascular disorder.